Silent Bacterial Genes Yield New Compounds for Possible Cancer Drugs
⏮ BeforeBacterial compounds with possible drug value were hard to obtain in quantity.
✅ NowResearchers have a new compound family and a synthetic route to make it.
In short
- Researchers at the Helmholtz Center for Infection Research and HIPS in Saarbrücken discovered a new family of compounds.
- The team worked out how the compounds are unusually made by the bacteria.
- They also developed a way to produce the compounds synthetically.
Why it's good news
Microorganisms are a known source of new medicines, but many of their genes stay silent under normal lab conditions. This work uncovers one family of these compounds and shows how to make them without relying on the original bacteria. The source describes them as potential leads, so they remain at an early research stage.
Advertisement
From Phys.org
Natural products produced by microorganisms are a promising source of new drugs. Researchers at the Helmholtz Center for Infection Research (HZI) and its Saarbrücken-based site, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), have now discovered a new family of such compounds, elucidated their unusual biosynthesis and developed a way to produce them synthetically.
Ask this story
More like this
Advertisement